Abdominal obesity in COPD is associated with specific metabolic and functional phenotypes

被引:4
作者
Cruthirds, Clayton L. [1 ]
Deutz, Nicolaas E. P. [1 ]
Mizubuti, Yani G. G. [1 ]
Harrykissoon, Rajesh I. [2 ]
Zachria, Anthony J. [2 ]
Engelen, Marielle P. K. J. [1 ]
机构
[1] Texas A&M Univ, Ctr Translat Res Aging & Longev, Dept Kinesiol & Sport Management, 675 John Kimbrough Blvd, College Stn, TX 77840 USA
[2] Scott & White Med Ctr, Pulm Crit Care & Sleep Med, College Stn, TX USA
关键词
Abdominal obesity; COPD; Branched-chain amino acids; Metabolism; OBSTRUCTIVE PULMONARY-DISEASE; CHAIN AMINO-ACIDS; BODY-COMPOSITION; SKELETAL-MUSCLE; BETA-BLOCKERS; RISK; PROFILES; PREVALENCE; BIOMARKERS; MORTALITY;
D O I
10.1186/s12986-022-00714-z
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Abdominal obesity (AO) is linked to reduced health status and mortality. While it is known that AO is prevalent in chronic obstructive pulmonary disease (AO-COPD), the specific metabolic and functional consequences associated with AO-COPD remain understudied.Methods: We studied 199 older adults with COPD and 168 control subjects with and without AO and assessed visceral adipose tissue (VAT) by dual-energy X-ray absorptiometry. VAT > 70th percentile of the control group qualified a subject as AO in a sex specific manner. We measured plasma concentrations and whole body production (WBP) rates of multiple amino acids to assess the metabolic profile. We assessed medical history, body composition by Dual Energy X-ray Absorptiometry, muscle strength, and cognitive function. We performed statistics by analysis of covariance (p) and FDR (q) for multiple comparisons. Results: AO-COPD subjects had 27% more VAT (q < 0.01) than AO-Control subjects despite correction for BMI. Branched-chain amino acid concentrations and WBP rates were generally elevated in AO-COPD but whole body clearance rate was only elevated in COPD. Metabolic syndrome comorbidities (p < 0.01) and systemic inflammation (P < 0.05) were most prevalent in the AO-COPD group. Muscle strength was reduced in COPD subjects (p < 0.001), but partially preserved when combined with AO. Cognitive dysfunction and mood disturbances were present in COPD subjects (p < 0.001) with worst performers in AO-COPD (q < 0.05). Conclusion: The presence of AO is associated with specific metabolic and functional phenotypes in COPD. Clinical trial registry Trial registration ClinicalTrials.gov. In the present paper, we report an analysis of the baseline measurements of COPD subjects and healthy controls from the study numbers: NCT01787682, NCT01787682, NCT02157844, NCT02082418, NCT02065141, NCT02770092, NCT02908425, NCT03159390, NCT02780219, NCT03327181, NCT03796455, NCT04928872, NCT04461236, NCT01173354, NCT01154400.
引用
收藏
页数:12
相关论文
共 54 条
[1]  
Abd El Aziz AA, 2017, EGYPT J CHEST DIS TU, V66, P247, DOI 10.1016/j.ejcdt.2017.03.006
[2]   USE OF A HEATED SUPERFICIAL HAND VEIN AS AN ALTERNATIVE SITE FOR THE MEASUREMENT OF AMINO-ACID-CONCENTRATIONS AND FOR THE STUDY OF GLUCOSE AND ALANINE KINETICS IN MAN [J].
ABUMRAD, NN ;
RABIN, D ;
DIAMOND, MP ;
LACY, WW .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1981, 30 (09) :936-940
[3]   Dietary intake of branched-chain amino acids in relation to general and abdominal obesity [J].
Asoudeh, Farzaneh ;
Salari-Moghaddam, Asma ;
Keshteli, Ammar Hassanzadeh ;
Esmaillzadeh, Ahmad ;
Adibi, Peyman .
EATING AND WEIGHT DISORDERS-STUDIES ON ANOREXIA BULIMIA AND OBESITY, 2022, 27 (04) :1303-1311
[4]   Normal Weight but Low Muscle Mass and Abdominally Obese: Implications for the Cardiometabolic Risk Profile in Chronic Obstructive Pulmonary Disease [J].
Beijers, Rosanne J. H. C. G. ;
van de Bool, Coby ;
van den Borst, Bram ;
Franssen, Frits M. E. ;
Wouters, Emiel F. M. ;
Schols, Annemie M. W. J. .
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2017, 18 (06) :533-538
[5]   Adaptive linear step-up procedures that control the false discovery rate [J].
Benjamini, Yoav ;
Krieger, Abba M. ;
Yekutieli, Daniel .
BIOMETRIKA, 2006, 93 (03) :491-507
[6]   Alterations of plasma metabolite profiles related to adipose tissue distribution and cardiometabolic risk [J].
Boulet, Marie Michele ;
Chevrier, Genevieve ;
Grenier-Larouche, Thomas ;
Pelletier, Melissa ;
Nadeau, Melanie ;
Scarpa, Julia ;
Prehn, Cornelia ;
Marette, Andre ;
Adamski, Jerzy ;
Tchernof, Andre .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2015, 309 (08) :E736-E746
[7]   Administration and interpretation of the trail making test [J].
Bowie, Christopher R. ;
Harvey, Philip D. .
NATURE PROTOCOLS, 2006, 1 (05) :2277-2281
[8]   Depression, body mass index, and chronic obstructive pulmonary disease - a holistic approach [J].
Catalfo, Giuseppe ;
Crea, Luciana ;
Lo Castro, Tiziana ;
San Lio, Francesca Magnano ;
Minutolo, Giuseppe ;
Siscaro, Gherardo ;
Vaccino, Noemi ;
Crimi, Nunzio ;
Aguglia, Eugenio .
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 11 :239-249
[9]   Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies [J].
Chan, Stanley M. H. ;
Selemidis, Stavros ;
Bozinovski, Steven ;
Vlahos, Ross .
PHARMACOLOGY & THERAPEUTICS, 2019, 198 :160-188
[10]   COgnitive-Pulmonary Disease [J].
Cleutjens, Fiona A. H. M. ;
Janssen, Daisy J. A. ;
Ponds, Rudolf W. H. M. ;
Dijkstra, Jeanette B. ;
Wouters, Emiel F. M. .
BIOMED RESEARCH INTERNATIONAL, 2014, 2014